We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Several new high strength insulin products are now on the market. The European Medicines Agency is consulting on guidance to minimise the risk of medication error.
Projects granted during 2015 that have a primary purpose of translational and applied research: human endocrine and metabolism disorders.
The UK regulator has taken safety action to reduce risks associated with Roche Accu-Chek Insight Insulin Pumps by issuing a national safety alert and outlining recommendations for patients.
We have issued a National Patient Safety Alert following serious reports of harm associated with insulin leakage during use of the Accu-Chek Insight Insulin pump with NovoRapid PumpCart prefilled insulin cartridges. Patients should be moved onto alternative insulin pumps where...
Projects granted during 2016 that have a primary purpose of translational applied research - human endocrine and metabolism disorders.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
The European Medicines Agency has advised that no change in recommendations for use is required at present.
Projects granted during 2014 that have a primary purpose of basic research: multisystemic.
People with diabetes using a particular type of insulin pump and pre-filled insulin cartridges should insert their cartridges correctly to avoid them leaking and potentially giving an under-delivery of insulin.
Report your diabetes to DVLA if you're a car driver or motorcyclist.
The MHRA continues to receive serious reports of harm associated with insulin leakage for the NovoRapid PumpCart prefilled insulin cartridge in the Accu-Chek Insight Insulin pump. In some patients, there were serious consequences arising from inadequate supply of insulin, including...
People with diabetes using the Accu-Chek Insight insulin pump system should check how they operate and wear the medical device to reduce the risk of an unwanted dose of insulin
People with diabetes are being reminded to seek medical advice before changing their insulin therapy devices.
If pioglitazone is used in combination with insulin patients should be observed for signs and symptoms of heart failure, weight gain, and oedema.
Care needed to minimise risk of error, including training for patients.
If patients are contacted directly by a manufacturer or other organisation to try using a different insulin therapy system they should first discuss this with their diabetes specialist to avoid risk of hyperglycaemia, hypoglycaemia or diabetic ketoacidosis.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).